Halozyme Secures European Patent For Enhanze Drug Delivery Platform

Halozyme Therapeutics, Inc, a biopharmaceutical firm, recently made the announcement that it had been granted European Patent No. 4269578. This patent covers the Enhanze rHuPH20 product that is made using Halozyme's Enhanze manufacturing methods...

Dept of Health Abu Dhabi and Opus Genetics Partner For Gene Therapy Research

Opus Genetics, a patient-first, clinical-stage gene therapy company developing treatments for inherited retinal diseases, and the Department of Health – Abu Dhabi (DoH), the Emirate's regulator of the healthcare sector, signed a Memorandum of...

AVS Bags IDE NOD From FDA For Pivotal Intravascular Lithotripsy Study

Amplitude Vascular Systems (AVS), a medical device company focused on the safe and effective treatment of severely calcified arterial disease, declared that it has received an investigational device exemption (IDE) from the United States Food and...

Orchid Pharma Bags DCGI Nod To Manufacture Antibiotic Drug

Orchid Pharma has secured Drugs Controller General of India (DCGI) endorsement for the manufacturing and promoting of its invented New Chemical Entity active pharmaceutical ingredient (API), enmetazobactam.DCGI has conceded consent to produce and...

Annogen Forays Research Collaboration with Orchard Therapeutics

Annogen, a biotechnology firm declared a research collaboration with Orchard Therapeutics, a worldwide gene therapy treatment pioneer, for the recognizable proof of immune cell-explicit human advertisers for use in specific pre-clinical...

Torrent Pharma Signs Pact with Tekeda to Commercialise GERD Drug

Torrent Pharmaceuticals announced that it has signed a non-exclusive patent licensing arrangement with Takeda to commercialize Vonoprazan in India. Vonoprozan is a new potassium-competitive acid blocker (P-CAB) that treats acid-related illnesses...

© 2024 India Pharma Outlook. All Rights Reserved.